Brief: Tarsus Reports Full-Year 2022 Financial Results And Recent Business Achievements

Tarsus Pharmaceuticals

13/03/2023 20:14

March 13 (Reuters) - Tarsus Pharmaceuticals Inc
 TARS.O :
    * TARSUS REPORTS FULL-YEAR 2022 FINANCIAL RESULTS AND RECENT
BUSINESS ACHIEVEMENTS
    * TARSUS PHARMACEUTICALS - CASH RUNWAY ANTICIPATED INTO AT
LEAST
2H 2026 TO SUPPORT PLANNED TP-03 COMMERCIALIZATION AND CONTINUED
PIPELINE DEVELOPMENT
    * TARSUS PHARMACEUTICALS : CASH RUNWAY ANTICIPATED INTO AT
LEAST
2H 2026 TO SUPPORT PLANNED TP-03 COMMERCIALIZATION AND CONTINUED
PIPELINE DEVELOPMENT
    * TARSUS PHARMACEUTICALS INC: FY NET LOSS PER SHARE, BASIC
AND
DILUTED $ 2.52
    * TARSUS PHARMACEUTICALS INC - AS OF DECEMBER 31, 2022,
CASH, CASH
EQUIVALENTS AND MARKETABLE SECURITIES WERE $217.0 MILLION

Source text for Eikon:  ID:nGNX12HTLQ 
Further company coverage:  TARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))